Home Tags Health research

Health research Related Content

UCLA School of Medicine

Gut Microbiome Research at the UCLA School of Medicine/GLAVA HCS

Professor Hannah Wexler discusses her work with Bacteroides fragilis, an important commensal in the gut microbiome but also the most important clinical anaerobic pathogen.
Muscular dystrophy

Muscular dystrophy: Present concerns and foreseen opportunities

Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
therapies for Huntington’s disease

Sources of funding in the development of therapies for Huntington’s disease

Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
antimicrobial resistance

UK Government invests £30 million to tackle antimicrobial resistance

The funding will be used to deliver four new projects as part of the Global AMR Innovation Fund (GAMRIF)
presenteeism

Mental Health Awareness: 8 out of 10 Brits admit observing presenteeism in the workplace

According to the recent CIPD survey, people coming into work when they are ill also known as ‘presenteeism’ has more than tripled since 2010, with 86% of employees admitting they had observed presenteeism in the workplace
spinal cords

ALS researchers begin recreating human spinal cords on a chip

NIH-funded study closes in on personalised drug testing for neurological disorders
thalassemia

Is 2018 the year we will see a cure for Thalassemia?

Multiple breakthroughs in gene therapy offer new hope for patients with genetic blood disorder, most common in Middle Eastern, Mediterranean, South Asian and African populations
Toxicology program

The health effects of exposure to chemicals and other substances

Open Access Government details the work of the National Toxicology Program, a world leader in providing scientific information to help evaluate and better understand the potential health effects of exposure to chemicals and other substances
type 2 diabetes

Accelerating innovative treatment for type 2 diabetes

Researchers from the University of Oxford and Novo Nordisk are collaborating to develop better treatments for type 2 diabetes

The Aplastic Anaemia Trust (AAT) launches its new research strategy

Today, The Aplastic Anaemia Trust (AAT) launches their new research strategy, inviting prospective applicants to come forward with proposals for truly translational research into aplastic anaemia (AA), as CEO Grazina Berry reveals
duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD)

Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
Endocrine Disruptors

Endocrine Disrupters: To Assess Or Not To Assess?

Endocrine Disrupting Chemicals (EDC) are chemical substances that can damage our health and/or the health of environmental organisms by altering the hormone function.
e-health

The emergence of personalised e-health care

CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients
governance of nano-related risk

Nano safety, advanced materials for the semiconductor industry and governance of nano-related risk

Dr Dimiter Prodanov from IMEC vzw shares his views on the fascinating world of nanomaterials including the governance of nano-related risk
University Hospital Bern

University Clinic of Nuclear Medicine

The University Clinic of Nuclear Medicine conducts examinations and treatments on patients with radioactive drugs. This includes radiation protection with its medical, physical and biological fundamentals
spinal muscular atrophy

New treatments for spinal muscular atrophy

SMA Europe e.V. discusses how new treatments for spinal muscular atrophy open up new challenges for European and national institutions
parkinson's disease

New research may benefit patients with early stage Parkinson’s disease

A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
early diagnosis

Dementia research: Early diagnosis of brain disorders

Jon Snaedal, professor in Geriatric Medicine, Landspitali University Hospital in Reykjavik, Iceland shares his expertise on dementia research including the early diagnosis of brain disorders
skin diseases

Arthritis, musculoskeletal and skin diseases including muscular dystrophy

The work of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, including muscular dystrophy (MD), is placed under the spotlight by Open Access Government
SCC

New research uses genomics to identify squamous cancer cells

Researchers at the National Institutes of Health (NIH) have used genomics to set apart squamous cancer cells (SCC’s) from other cancers. This could improve treatments for head and neck cancers.

Latest Articles